Attitudes and Beliefs of an Albino Population Toward Sun Avoidance
Authors:
- Sandy R. McBrideSMSandy R. McBride
- Barbara J. LeppardBLBarbara J. Leppard
Open Access
- 1 May 2002
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 138 (5) , 629-632
Abstract
OCULOCUTANEOUS albinism type II is an autosomal recessive condition resulting from a mutation in the P gene encoding for a transmembrane melanosomal transport protein. The consequent reduction in cutaneous melanin increases the risk of nonmelanoma skin cancer.1-3 In the eye, a reduction in pigment at the fovea leads to poor central vision, nystagmus, and photophobia.4 The overall incidence of oculocutaneous albinism type II in Tanzania is 1 in 1400 people per year.5 In tropical countries where there is an additional risk factor of continual daily sun exposure, many albinos die in their 20s and 30s of nonmelanoma skin cancer.6,7Keywords
This publication has 7 references indexed in Scilit:
- Prevalence of Skin Disease in Rural Tanzania and Factors Influencing the Choice of Health Care, Modern or TraditionalArchives of Dermatology, 1998
- Knowledge, attitudes and reported behaviours relevant to sun protection and suntanning in adolescentsPsychology & Health, 1996
- Oculocutaneous albinism among schoolchildren in Harare, Zimbabwe.Journal of Medical Genetics, 1995
- Actinic damage and skin cancer in albinos in northern Tanzania: Findings in 164 patients enrolled in an outreach skin care programJournal of the American Academy of Dermatology, 1995
- Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene.Proceedings of the National Academy of Sciences, 1994
- A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinismNature, 1993
- The Tanzanian human albino skin. Natural historyCancer, 1985